BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 21826080)

  • 1. Management of hepatorenal syndrome in patients with cirrhosis.
    Arroyo V; Fernández J
    Nat Rev Nephrol; 2011 Aug; 7(9):517-26. PubMed ID: 21826080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatorenal syndrome].
    Huschak G; Kaisers UX; Laudi S
    Anaesthesist; 2013 Jul; 62(7):571-82. PubMed ID: 23846211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs.
    Barbano B; Sardo L; Gigante A; Gasperini ML; Liberatori M; Giraldi GD; Lacanna A; Amoroso A; Cianci R
    Curr Vasc Pharmacol; 2014 Jan; 12(1):125-35. PubMed ID: 24678726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
    Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
    United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy.
    Arroyo V
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():49-54; discussion 55-6. PubMed ID: 15335402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatorenal syndrome.
    Ginès P; Guevara M; Arroyo V; Rodés J
    Lancet; 2003 Nov; 362(9398):1819-27. PubMed ID: 14654322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and treatment of hepatorenal syndrome.
    Arroyo V; Fernandez J; Ginès P
    Semin Liver Dis; 2008 Feb; 28(1):81-95. PubMed ID: 18293279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
    Arroyo V; Jiménez W
    J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatorenal syndrome.
    Bataller R; Ginès P; Arroyo V; Rodés J
    Clin Liver Dis; 2000 May; 4(2):487-507. PubMed ID: 11232202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy insight: Management of hepatorenal syndrome.
    Cárdenas A; Ginès P
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):338-48. PubMed ID: 16741553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatorenal syndrome].
    Ben Chaabane N; Melki W; Hellara O; Safer L; Bdioui F; Saffar H
    Tunis Med; 2011 Dec; 89(12):885-90. PubMed ID: 22198887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal impairment in liver diseases].
    Gerbes AL; Gülberg V
    Praxis (Bern 1994); 2006 Oct; 95(40):1535-8. PubMed ID: 17048410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential treatment of hepatorenal syndrome and posthepatic cirrhosis by intrahepatic portosystemic shunt (TIPSS) and liver transplantation.
    Lerut J; Goffette P; Laterre PF; Donataccio M; Reynaert MS; Otte JB
    Hepatogastroenterology; 1995; 42(6):985-7. PubMed ID: 8847056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatorenal syndrome].
    Baccaro ME; Guevara M
    Gastroenterol Hepatol; 2007 Nov; 30(9):548-54. PubMed ID: 17980134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute kidney injury and hepatorenal syndrome in cirrhosis.
    Egerod Israelsen M; Gluud LL; Krag A
    J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatorenal syndrome.
    Cárdenas A; Arroyo V
    Ann Hepatol; 2003; 2(1):23-9. PubMed ID: 15094702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatorenal syndrome].
    Radziszewski A; Sułowicz W
    Przegl Lek; 2006; 63(7):573-8. PubMed ID: 17203812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatorenal Disorders.
    Al-Khafaji A; Nadim MK; Kellum JA
    Chest; 2015 Aug; 148(2):550-558. PubMed ID: 25811649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.